Blog

  • Looking for More iPhone Battery Life? Adaptive Power in iOS 26 Should Provide a Boost

    Looking for More iPhone Battery Life? Adaptive Power in iOS 26 Should Provide a Boost

    People who have installed the latest iOS 26 public beta or developer beta are discovering a simple switch that just might deliver long-term iPhone benefits — and it’s an Apple Intelligence feature of all things. Adaptive Power is an unobtrusive feature tucked a couple of layers deep into the Battery settings that uses AI to extend battery life when usage is higher than normal.

    See also: Adaptive Power in iOS 26 Could Save the iPhone 17 Air From This Major Pitfall

    Currently, the iPhone uses as much power as it needs to perform its tasks. You can extend the battery life by doing a number of things, such as decreasing screen brightness and turning off the always-on display. Or, if your battery level is starting to get dire, you can activate Low Power Mode, which reduces background activity like fetching mail and downloading data in addition to those screen adjustments. Low Power Mode also kicks in automatically when the battery level reaches 20%.

    If Low Power Mode is the hammer that knocks down power consumption, Adaptive Power is the scalpel that intelligently trims energy savings here and there as needed. Based on Apple’s description that accompanies the control, the savings will be felt mostly in power-hungry situations such as recording videos, editing photos or perhaps even playing games:

    “When your battery usage is higher than usual, iPhone can make small performance adjustments to extend your battery life, including slightly lowering the display brightness or allowing some activities to take a little longer. Low Power Mode may turn on at 20%.”

    Watch this: I’m Impressed With iOS 26. Apple Just Made iPhones Better

    How to turn adaptive power on

    Adaptive Power is not on by default, and you must opt in to use it. In iOS 26, you’ll find the Adaptive Power toggle in Settings > Battery > Power Mode. 

    ios26-adaptive-power-settings

    In iOS 26, turn on the Adaptive Power option to help extend battery life. (IOS 26 developer build shown here.)

    Screenshot by Patrick Holland/CNET

    Since Adaptive Power appears to use AI to decide which settings and processes to adjust, the feature appears to be available only on iPhone models that support Apple Intelligence, which include the iPhone 15 Pro and later. A Reddit thread about Adaptive Power suggests this is the case, with commenters noting it doesn’t show up in iPhone 13 Pro or iPhone 14 Pro models with the beta installed.

    Adaptive Power sounds like an outgrowth of Gaming Mode, introduced in iOS 18, which routes all available processing and graphics power to the frontmost app and pauses other processes in order to deliver the best experience possible — at the notable expense of battery life.

    iPhone screenshot showing a notification that says "Adaptive Power: iPhone is adjusting performance to help extend your battery life."

    When the iPhone is using Adaptive Power, a notification appears.

    Screenshot by Jeff Carlson/CNET

    What does this mean for your charging habits?

    Although we all want as much battery life as possible all the time, judging by the description it sounds as if Adaptive Power’s optimizations will not always be active, even if you leave the feature on. “When your battery usage is higher than usual” could include a limited number of situations. Still, considering that according to a CNET survey 61% of people upgrade their phones because of battery life, a feature such as Adaptive Power could extend the longevity of their phones just by updating to iOS 26.

    I also wonder whether slightly adjusting display brightness could be disruptive. But because the feature is also selectively de-prioritizing processing tasks, it suggests that the outward effects will be minimal.

    We’ll know more about how well Adaptive Power works as the iOS 26 beta program nears the expected release date in September or October — battery optimizations are often the last tweaks to be made to operating systems in development just before shipping. If you want to start giving iOS 26 a spin, you can download the first public beta now. Just remember that beta software carries risks, especially these first iterations that have recently been set loose from Apple’s labs.


    Continue Reading

  • White & Case advises Hyva on sale of global cranes business to Mutares

    White & Case advises Hyva on sale of global cranes business to Mutares

    Global law firm White & Case LLP has advised Hyva, a leading provider of transport solutions for commercial vehicles, and its parent JOST Werke SE (JOST), on the sale of Hyva’s global cranes business to private equity investor Mutares.

    Hyva’s cranes division designs, manufactures and services truck-mounted cranes, with manufacturing and assembly facilities in Italy, Brazil and China and a global network of sales and distribution offices and generates annual revenue of approximately €100 million.

    The divestment follows JOST’s earlier acquisition of Hyva and forms part of its strategy to focus on integrating Hyva’s core portfolio. The divestment is expected to close during the fourth quarter of 2025, subject to the implementation of the legal carve-out of the crane business in multiple jurisdictions and customary closing conditions.

    The White & Case team which advised on the transaction was led by partners Stefan Bressler (Frankfurt & Hamburg) and Thilo Diehl (Frankfurt) and included partners Thilo Wienke (Düsseldorf), Sebastian Stütze, Bodo Bender (both Frankfurt), Orion Berg (Paris) and Alan Bao (Beijing), local partners Mathias Bogusch and Alisa Preissler (both Frankfurt) and associates Fabian Mayer (Berlin), Maximilian Eichhorn, Enno Miedtank (both Hamburg) and Qianru Hong (Shanghai).

    Press contact
    For more information please speak to your local media contact.

    Continue Reading

  • Chess: Adams wins ninth British title, while 10-year-old girl breaks two world records | Chess

    Chess: Adams wins ninth British title, while 10-year-old girl breaks two world records | Chess

    Michael Adams edged nearer the all-time record for British Championship titles last weekend when the Taunton-based grandmaster won his ninth national championship at Liverpool.

    Adams, who relaxes by watching cricket at Somerset’s county ground, has now equalled Henry Atkins’s total of nine championships from the first half of the last century, but remains one short of Jonathan Penrose’s 10 crowns from the second half. Adams’s first British title was in 1989 at age 17, still the youngest ever, but in the next 20 years he concentrated on the world championship, coming within a hair’s breadth of a reunification match with Garry Kasparov in 2004 before losing in the Fide final.

    Starting with 2010, Adams made the British championship his priority, and he won five crowns in the next decade. Literally so, for the event trophy has been in the shape of a crown since the very first championship in 1904, and engravers now struggle to find space on it to add new names.

    Michael Adams with the British Championship trophy Photograph: Yuri Krylov/English Chess Federation

    Between 2010 and 2019 Adams won the British title five times, setting up his current record attempt. He still retains his international ambitions, is the reigning world over-50 champion, and is competing in the strong Rubinstein Memorial beginning on Friday at Polanica-Zdroj, Poland.

    Two titles are still required before Adams can surpass the 10 championships of the late Penrose, and that may be difficult. A new generation of talents is emerging in England, encouraged by a £1.5m support grant over three years for elite talents announced by the chancellor, Rachel Reeves, last month. The funding, which will start in April 2026, will be split equally between the Department for Education and the Department for Culture, Media and Sport.

    The pre-tournament favourite and top seed was Nikita Vitiugov, but the former Russian champion struggled to find his best form and was defeated decisively by Stuart Conquest in the final round, in an encounter which was awarded the joint best game prize.

    The 2025 championship was keenly fought, with six players sharing the lead at the start of round nine. Adams won after a speed tie-break with fellow veteran Conquest, 58. Final leading scores were Adams, Conquest, and Peter Roberson (eliminated in the first round of tie-breaks) 7/9, Gawain Maroroa Jones, Svyatoslav Bazakutsa (Ukraine), and Jonah Willow 6.5.

    3985: IM Siva Mahadevan v GM Nikita Vitiugov, British Championship, Liverpool 2025.
    Black to move and win.

    The championship marked a breakthrough for junior talent. England’s youngest ever grandmaster Shreyas Royal, 17, was among the leaders for seven rounds, including an elegant win against Marcus Harvey, before falling into a trap against Conquest.

    Bodhana Sivanandan, 10, continues to break records. The Harrow primary schoolgirl, who at eight won three world girls gold medals with a combined total of 33 straight wins, achieved her third and final norm for the WIM title with a 2300 rating performance, a full year younger than the previous record.

    In the final round, Sivanandan became the youngest girl ever to defeat a grandmaster in a classical game when GM Peter Wells overstepped the time limit in a lost position.

    At 10 years five months, Sivanandan was six months younger than the previous world record holder, Carissa Yip of the US, who defeated GM Alexander Ivanov at the 2014 New England Open (not 2019, as widely misquoted) aged 10 years 11 months. Yip has been the US woman champion for the past two years. Three-time British champion and taketaketake.com host David Howell called Sivanandan’s achievement “extraordinary”.

    skip past newsletter promotion

    Supratit Banerjee did best of the rising talents. The Surrey 11-year-old achieved his first international master norm, easily a UK age record, defeated two grandmasters in succession, and displayed remarkable maturity and stamina, including drawing a 145-move game.

    Banerjee is again in action this week at the Kingston Invitational organised by the Guardian’s Stephen Moss followed immediately by the Northumbria Masters in Newcastle. It is a tough schedule for an 11-year-old. The Mindsports International is also under way in London.

    There was criticism of the British Championship format after round eight of nine came with 28 players, more than a quarter of the field, separated by just a single point. Possible remedies are to restore an 11-round championship, with two extra double round days early on; and/or raising the rating floor for entries. However, Alex Holowczak, the influential English Chess Federation director of events, has said: “I see one round per day as sacrosanct for the British.”

    The prize money (Adams received £4,400) is low for an era in which life-changing amounts are on offer for international chess events. When the government grant for elite talent becomes available, it would be reasonable to earmark at least £25,000 to boost the national championship prize money at the University of Warwick in August 2026.

    In 1954, first prize in the British Championship was £35 and second was £15. They were shared after several weeks of a 10-game playoff. Just saying …

    3985: 1…Rxd6! 2 Qxd6 (else Black wins with his extra knight) Bf3! 3 Resigns. If 3 g3 (to stop Qxg2 mate) Qc1+ 4 Bd1 Qxd1+ 5 Kh2 Qh1 mate.

    Continue Reading

  • Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis

    Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis

    A recently published propensity score-weighted comparative study using a target trial emulation found that rituximab had superior effectiveness over cladribine (Mavenclad; EMD Serono) in controlling MRI disease activity in patients with relapsing multiple sclerosis (MS) over a median follow-up of 4.5 years. The head-to-head study adds long-term, high-quality data that may guide treatment decisions, the study authors wrote.

    The observational study comprised 285 patients from the Nowegian MS Registry and Biobank who were on either rituximab (n = 159) or cladribine (n = 126). Investigators emulated a target trial, a methodological approach done to mimic the structure of a hypothetical randomized controlled trial. Patients were primarily assessed on MRI disease activity, with secondary outcomes that included relapses, disability progression, and safety.

    Results from the study showed a 17% (95% CI, 11-23) risk of new MRI disease activity at the 4-year mark for those on rituximab vs a 57% (95% CI, 44-66) risk for cladribine-treated patients. At 6 months, 2 years, and 4 years after treatment initiation, patients treated with rituximab vs cladribine had risk differences (RDs) of 23 (95% CI: 15–35), 34 (95% CI: 23–43), and 40 (95% CI: 28–50) percentage points, and risk ratios (RRs) of 0.34 (95% CI: 0.19–0.51), 0.31 (95% CI: 0.21–0.47), and 0.30 (95% CI: 0.20–0.44), respectively.

    “These high-quality long-term data, especially on MRI and safety outcomes, provide valuable insights for treatment decisions,” lead author Brit Ellen Rød, PhD, postdoctoral researcher at the University of Bergen, and colleagues, wrote. “However, RCTs are warranted to confirm these findings in fully comparable cohorts and to capture more comprehensive disability outcomes.”

    Additional data over that 4.5-year period revealed that those on rituximab were free of new MRI disease activity for a mean of 16.8 months (95% CI, 10.7-23.4) longer than those treated with cladribine. On secondary outcomes, the study demonstrated lower 4-year relapse risk for rituximab as well (6% vs 17%; P = .0012), with less discontinuations (7% vs 21%; P <.0001). Of note, the primary reason for discontinuing rituximab was side effects, whereas for cladribine it was ongoing disease activity.

    READ MORE: Real-World Analysis Shows Growing Use of Octave’s MS Disease Activity Test in Clinical Practice

    The study took advantage of a near-random difference in treatment preferences between two Norwegian hospitals, with allocation largely determined by patients’ residential addresses. Norway’s homogeneous population, standardized healthcare system, national MS guidelines, and the high-coverage Norwegian MS Registry enabled real-world, long-term effectiveness assessment across a broad patient population, including those often excluded from RCTs.

    After 4 years, CDP incidence did not differ significantly between rituximab (9%, 95% CI, 2–16) and cladribine (19%, 95% CI, 3–32; P = 0.32), but CDI was more frequent with rituximab (21%, 95% CI, 9–32) than cladribine (4%, 95% CI, 0–9; P = 0.026), with an RD of 18 percentage points (95% CI, 4–29) and RR of 0.16 (95% CI, 0.0–0.7). There were no statistically significant differences in neurofilament light levels (P = .18); however, rituximab-treated patients showcased lower glial fibrillary acidic protein (GFAP) levels (62.8 pg/mL vs 87.8 pg/mL; P = .021).

    The main limitation of the study was the lack of randomization and potential unmeasured confounders, though sensitivity analyses and alignment with prior RCTs support the reliability of results. Other limitations included scarce EDSS data, single-time-point biomarker measurements, and variable timing between baseline MRI and treatment start, but these did not alter the consistent treatment differences observed.

    In terms of safety, the incidence of hospitalizations related to possible adverse events was slightly higher in rituximab-treated patients (6.0 per 100 person-years vs 4.1), with COVID-19 being the most frequent reason for hospitalization. There were no deaths during the follow-up period, the authors noted.

    REFERENCE
    1. Rød BE, Hogestol EA, Torkildsen O, et al. Comparative effectiveness of rituximab and cladribine in relapsing–remitting multiple sclerosis: A target trial emulation. Multiple Scler Journal. 2025;31(8). doi: 10.1177/13524585251342727

    Continue Reading

  • Fateless raises $14 million for its new cross-platform RPG

    Fateless raises $14 million for its new cross-platform RPG

    Indie studio Fateless has raised $14 million in funding for its upcoming RPG, Godforge.

    Formed in May 2023 around the HellHades Gaming (HH Gaming) brand, Fateless announced in July 2024 that it had raised an initial $6 million in funding within just 10 weeks of its start.

    The U.K.-based studio has now raised an additional $8 million in a second round of funding, according to a press release published on August 14, 2025.

    According to Fateless, the total $14 million it has raised so far has primarily been driven by its HH Gaming and HellHades community members.

    The funding is being used to develop the studio’s debut title, Godforge, a cross-platform RPG due to release in Q1 2026.

    Godforge is currently in Alpha, with the first wave now complete. On August 7, 2025, Fateless shared statistics from this test on LinkedIn, which revealed 4,421 players logged in to the game during wave one, logging a total of 45,776 play hours.

    “With an already engaged and proven audience of over [two] million players across our YouTube channels, website, Discord, and social media, we’re excited and confident that Godforge will help evolve the hero collector genre for the next generation of players,” said Simon”HellHades” Lockerby, co-founder and CEO of Fateless.

    “More importantly, the community has already expressed great belief in the game by helping us raise funds of $6 million during our initial startup phase, and was a major contributor to our latest round.”

    Continue Reading

  • Bodhana Sivanandan: 10-year-old chess prodigy becomes youngest female player to defeat grandmaster

    Bodhana Sivanandan: 10-year-old chess prodigy becomes youngest female player to defeat grandmaster

    A 10-year-old British girl has made chess history by becoming the youngest female player to ever beat a grandmaster.

    Bodhana Sivanandan, from northwest London, defeated 60-year-old grandmaster Pete Wells in the final round of the 2025 British Chess Championships in Liverpool on Sunday.

    At 10 years, five months and three days, Sivanandan broke the record set by American Carissa Yip, who was 10 years, 11 months and 20 days old when she defeated a grand master in 2019, according to the International Chess Federation (FIDE).

    Sivanandan has now earned woman international master status, one level below the female-exclusive woman grandmaster title; the highest title in chess is grandmaster, owned by the likes of current world chess champion Gukesh Dommaraju and world No. 1 Magnus Carlsen.

    Her dad told the BBC in 2024 that “nobody at all” in their family had previously excelled at chess.

    Sivanandan said she picked up the sport during the Covid pandemic when she was five, after one of her dad’s friends gifted them some toys and books.

    “In one of the bags, I saw a chessboard, and I was interested in the pieces,” she told the BBC.

    “I wanted to use the pieces as toys. Instead, my dad said that I could play the game, and then I started from there.”


    Continue Reading

  • ‘They won’t suffer anymore’: Karachi mother’s cold confession to killing kids – ARY News

    1. ‘They won’t suffer anymore’: Karachi mother’s cold confession to killing kids  ARY News
    2. Mother arrested after allegedly killing her two children in case that stuns Pakistan  Arab News
    3. Karachi police arrest DHA woman for allegedly murdering her two young children  Dawn
    4. Mother slits throats of two in DHA  The Express Tribune
    5. Mother killed two children in Karachi Breaking  Independent News Pakistan

    Continue Reading

  • Personalized Walking Pattern May Reduce Knee Osteoarthritis Symptoms, Delay Progression

    Personalized Walking Pattern May Reduce Knee Osteoarthritis Symptoms, Delay Progression

    Valentina Mazzoli, PhD

    Credit: NYU Grossman School of Medicine

    Personalized foot angle modifications based on individual walking patterns may help improve pain, reduce knee loading, and slow cartilage breakdown in individuals with medial compartment knee osteoarthritis, according to findings from a recent study.1

    In the single-center, parallel-group, randomized controlled trial, participants underwent 6 walking retraining visits and received real-time biofeedback instructing them to walk consistently with a personalized target foot progression angle. Results showed participants in the intervention group who targeted a 5° or 10° change in foot progression angle that maximally reduced their knee loading experienced greater reductions in medial knee pain and knee adduction moment peak.1

    “Although our results will have to be confirmed in future studies, they raise the possibility that the new, noninvasive treatment could help delay surgery,” said study co-lead author Valentina Mazzoli, PhD, an assistant professor in the Department of Radiology at NYU Grossman School of Medicine.2

    According to the US Centers for Disease Control and Prevention (CDC), about 33 million US adults have some form of osteoarthritis, commonly in the inner side of the knee. In the absence of a cure, treatment seeks to manage symptoms and reduce pain, often with physical activity, maintaining a healthy weight, pharmaceutical pain relievers, physical therapy, and in severe cases, knee replacement surgery.1,3

    Of note, the CDC recognizes repetitive joint stress or injury as a risk factor for osteoarthritis, posing important implications for the potential therapeutic benefits of adjusting gait to lessen extra loading.3

    To explore the impact of personalized gait retraining for medial compartment knee osteoarthritis, investigators conducted a single-center, parallel-group, randomized controlled trial of individuals with symptomatic medial compartment knee osteoarthritis at the Human Performance Laboratory and Lucas Center for Imaging at Stanford University using online and print media.1

    Eligible participants ≥18 years of age underwent 6 walking retraining visits to a university gait laboratory and received real-time biofeedback instructing them to walk consistently with a personalised target foot progression angle. The intervention group’s target was the 5° or 10° change in foot progression angle that maximally reduced their knee loading, while the sham group’s target was their natural foot progression angle. Participants and staff involved in data analysis were masked to group allocation, but staff performing the gait analysis visits were not.1

    Primary outcomes were 1-year changes in medial knee pain and medial knee loading as measured by knee adduction moment peak. Secondary outcomes were 1-year changes in cartilage microstructure estimated from MRI (T1ρ and T2 relaxation times).1

    Between Aug 2016 and June 2019, 1582 individuals were screened for eligibility, 107 participants completed an initial gait analysis, and 68 were randomly assigned to either the intervention (n = 34) or the sham (n = 34) group. Among the cohort, 41 (60%) participants were female, 54 (79%) were White, and the mean age was 64.4 (standard, deviation, 7.6) years.1

    After 1 year, participants in the intervention group experienced greater reductions in medial knee pain (between-group difference, –1.2; 95% CI –1.9 to –0.5; P = .0013) and knee adduction moment peak (between-group difference, –0.26 % bodyweight × height; 95% CI, –0.39 to –0.13; P = .0001) than participants in the sham group.1

    Investigators noted the MRI-estimated change in cartilage microstructure (T1ρ) in the medial compartment was less in the intervention group than the sham group (between-group difference, –3.74 ms; 95% CI, –6.42 to –1.05) but did not observe any significant between-group differences in T2.1

    While there were no severe adverse events; 2 (6%) participants in the intervention group and 1 (3%) participant in the sham group dropped out of the study due to increased knee pain.1

    “Altogether, our findings suggest that helping patients find their best foot angle to reduce stress on their knees may offer an easy and fairly inexpensive way to address early-stage osteoarthritis,” Mazzoli concluded.2

    References
    1. Uhlrich SD, Mazzoli V, Silder A, et al. Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial. The Lancet. doi:10.1016/S2665-9913(25)00151-1
    2. NYU Langone. Study Reveals How Small Changes in Walking Technique May Help Treat Knee Osteoarthritis. August 13, 2025. Accessed August 14, 2025. https://nyulangone.org/news/study-reveals-how-small-changes-walking-technique-may-help-treat-knee-osteoarthritis
    3. US Centers for Disease Control and Prevention. Osteoarthritis. January 26, 2024. Accessed August 14, 2025. https://www.cdc.gov/arthritis/osteoarthritis/index.html

    Continue Reading

  • Optics & Photonics News – Entrepreneurs to Watch: Robert Bedington

    Optics & Photonics News – Entrepreneurs to Watch: Robert Bedington

    Robert Bedington. [Image: SpeQtral]

    As part of our biennial Entrepreneurs to Watch feature, Optics & Photonics News spoke with Robert Bedington, cofounder and CTO of SpeQtral, a Singapore-based quantum communications company developing satellite-based quantum key distribution (QKD) systems. SpeQtral emerged from academic research into entangled photon sources and is now on the verge of launching one of the first commercial QKD satellites outside of China.

    Tell me about your journey into entrepreneurship. How did you get started?

    My background is in physics. I studied at Durham University, UK, where I focused on astronomical instrumentation for my master’s project. That led me to pursue a Ph.D. at University College London’s Mullard Space Science Laboratory, working on satellite-based space weather analyzers—electron and ion spectrometers for small satellites.

    Later, I did a postdoc in Japan, continuing the miniaturization of those devices. Around that time, I reconnected with an old school friend who had moved to Singapore and was working at the Centre for Quantum Technologies (CQT) at the National University of Singapore. He told me they were developing miniaturized quantum experiments for space and needed someone with satellite experience. That’s how I joined the team.

    At CQT, we developed a 3U CubeSat called SpooQy-1, a 30×10×10 cm satellite that demonstrated quantum entanglement in orbit. I led the satellite team under Professor Alexander Ling. We built a robust entangled photon source and integrated it into the satellite, which launched in 2019 via the Japanese Space Agency and deployed from the International Space Station. It operated until it deorbited in 2021 and successfully demonstrated quantum entanglement in space throughout that time.

    And that was the catalyst for launching the company?

    Exactly. SpooQy-1 generated a lot of commercial interest. People kept asking if they could buy one of these QKD satellites, and we’d say, “We’re a university. We don’t sell satellites.” But that got us thinking.

    SpeQtral-1 satellite

    SpeQtral-1 satellite. [Image: SpeQtral]

    In late 2017, we set up a company called S15 Space Systems—named after the university block we worked in: Science Site 15. At first, we collaborated closely with the university, handling contracted research and satellite operations. Then in 2019, after securing funding, we acquired our own offices and labs and transitioned the team into what’s now SpeQtral.

    So it was a natural progression from research group to startup…

    Very much so. The research group always had a startup-like atmosphere. We were a team of postdocs and researchers working toward the shared goal of launching a satellite. That’s not so typical in academia, where people usually have individual projects. So when the time came to spin out, the transition felt organic.

    Tell me more about the technology. Why is quantum entanglement in space important?

    The near-term application is quantum key distribution, or QKD. It’s a method of securely sharing random numbers—used as encryption keys—between two parties. What makes QKD different is that it’s based on the laws of quantum physics. Any eavesdropping attempt disturbs the system and is detectable.

    This is especially relevant because current encryption relies on mathematical complexity—things like factoring large primes—which quantum computers will eventually break. With QKD, the security isn’t based on assumptions or computational difficulty. The method is proven to be secure from the outset.

    So this is about future-proofing encryption—especially for critical infrastructure.

    Yes, it’s not about protecting casual web browsing. It’s about securing high-value data—banking systems, government communications, data center interconnects. And banks are already early adopters. I just came back from a banking conference where interest was high.

    How is SpeQtral’s approach unique in optics and photonics?

    Our systems are much smaller and more cost-effective than existing solutions. There are only a handful of serious efforts in satellite QKD—most notably China’s Micius satellite, which demonstrated QKD in 2017.

    SpeQtral logo

    [Image: SpeQtral]

    Outside of that, there have only been partial demos. SpooQy-1, for instance, was an early proof of concept. Some German and other European efforts have followed, but no one else has yet matched China’s full-scale entanglement distribution missions.

    We’ll likely be among the first to follow. Our mission, launching later this year, uses entanglement-based QKD—a more secure but technically complex approach. Many systems use “weak coherent pulses,” which approximate single photons. These are easier to implement but have weaker security guarantees. Our system starts with true entangled photon pairs, which can enable secure key exchange even without trusting the satellite—though our first mission will still require some trust.

    That sounds like a significant milestone. When is the launch?

    The window is October to November 2025. After that, we’ll enter a commissioning phase that could take three to six months. Like many satellite programs, deadlines shift, but we’re getting close.

    What’s been the biggest challenge since launching SpeQtral?

    Many, honestly. The technology is complex, but the business side presents its own hurdles. QKD doesn’t replace an existing system directly—it supplements existing cryptography. So productizing it, explaining it, integrating it into broader security infrastructures… all of that takes time and coordination.

    Certification, standardization, export controls—these are dry but critical aspects that we and others in the QKD field are still working through.

    Hiring has also been hard. During the pandemic, it was tough to attract people to Singapore, especially because much of our work is hands-on. Even seemingly minor things, like changes to spousal work visas, made a big impact. Still, we’ve built a strong, international team.

    And because we work with global partners—most of them in Europe—we face the usual challenges of remote technical collaboration across time zones. It takes a lot of effort to make those relationships run smoothly.

    As a leader, what do you wish you’d known at the beginning?

    That it’s okay to deliver value in smaller steps. We jumped straight into satellites. Looking back, I think we could have prioritized intermediate deliverables—smaller, more immediate revenue-generating products that build toward the big vision.

    We’ve done some of that, but I’d put more emphasis on it next time. It helps with funding, morale, and customer engagement.

    How do you keep innovation alive in this kind of environment?

    Innovation is baked into our DNA. We didn’t really start from scratch—we spun out from a research group. So there’s always been a culture of experimentation and pushing boundaries.

    But we also brought in people from industry to help make things robust, reliable, and commercially viable. It’s a balance—keeping the academic curiosity while building a company that ships.

    TARQIS, SpeQtral's Mobile Quantum Optical Ground Station (Q-OGS)

    TARQIS, SpeQtral’s Mobile Quantum Optical Ground Station (Q-OGS). [Image: SpeQtral]

    What happens after this year’s launch? What’s next for you and SpeQtral?

    We’re already working on the follow-on mission. It will include both an entangled photon source and a weak coherent pulse source. The latter can deliver higher key rates, though with slightly less security.

    We’re also integrating laser communications, which will replace radio links and increase data rates significantly.

    Longer term, we’re exploring a range of quantum-based key distribution techniques. Not every use case needs the gold standard. Some commercial clients may not face the kind of threats that justify the most secure (and expensive) systems. So we’re thinking about cost-performance trade-offs and tailoring solutions to different needs.

    You’re talking about a spectrum of solutions, depending on the risk model.

    Exactly. Not everyone needs to protect against the threat of stealth satellites or hypersonic drones as potential eavesdroppers. If your adversaries are less advanced, a lower-cost solution might be enough.

    We want to help customers understand their threat models so they can choose the right level of quantum security.

    What trends are shaping the future of your industry?

    The biggest one is, of course, quantum computing. It’s still early days, but it will eventually break current encryption. That’s why organizations are acting now to secure critical communications.

    Even if quantum computing is still five or ten years off, the data you transmit today can be stored and decrypted later. That’s what people call “harvest now, decrypt later.”

    Further out, we’re looking at quantum networking—linking quantum computers over entangled networks. That would enable shared computation and massive increases in capability. Imagine entangling telescopes on opposite sides of the planet to create a virtual telescope the size of the Earth.

    That’s decades away, but the infrastructure we’re building now—satellite QKD, entangled photon networks—is the foundation for that future. There’s a long road ahead, but also incredible potential. We’re trying to help build the quantum internet, piece by piece.

    Continue Reading

  • Natalie Portman, Mila Kunis, and Darren Aronofsky on 15 Years of ‘Black Swan’

    Natalie Portman, Mila Kunis, and Darren Aronofsky on 15 Years of ‘Black Swan’

    It took Aronofsky and Portman over a decade—and a lot of “kicking and screaming,” as he puts it—to convince Fox Searchlight to put up half of the film’s $13 million budget and ultimately get Black Swan into theaters. But to be fair, when have studio executives ever foamed at the mouth to make an arthouse horror film set in the world of ballet, one that ends with its heroine taking her own life?

    Photo: Courtesy of Searchlight Pictures

    “Everyone passed on Black Swan, and I mean everyone,” Aronofsky says. “There was one executive who said the movie would never work because ‘ballet fans don’t like horror, and horror fans don’t like ballet.’”

    Yet his and Portman’s belief in the material paid off. When Black Swan debuted in December 2010, it raked in nearly $330 million worldwide, becoming Fox Searchlight’s second-highest-grossing film to date after Slumbdog Millionaire. Portman won the best-actress Oscar for her electrifying performance, and the film received four other nominations—for best picture, director, cinematography, and editing—among numerous other accolades.

    This summer, on August 21 and 24 only, a newly remastered version of the film will play on IMAX screens across the country, where attendees can also snag—on a first-come, first-serve basis—a limited-edition, double-sided poster created exclusively for the re-release. And in December, Rodarte—which produced a few key costumes in the film, including Portman’s show-stopping stage looks for the finale—will launch a limited-edition Black Swan capsule collection.

    Image may contain Dancing Leisure Activities Person Ballerina Ballet Adult Wedding Face Head and Photography

    Photo: Courtesy of Searchlight Pictures

    Image may contain Rolene Strauss Dancing Leisure Activities Person Adult Ballerina and Ballet

    Photo: Courtesy of Searchlight Pictures

    Here, to commemorate 15 years of Black Swan, Aronofsky, Portman, and Kunis reunited to chat with Vogue about the making of the film.

    Continue Reading